Ineffective health technology assessment (HTA) procedures for innovative medicines in Ecuador
in EcuadorTrade barrier summary
Ecuador's HTA processes lack coordination and predictability due to decentralised management of these. This harms UK pharmaceutical exports by undermining the adoption of innovative and cost-effective UK drugs in the Ecuadorean health system.
Sectors affected
- Pharmaceuticals and biotechnology
- Medical devices and equipment
- Healthcare services
Resolved
No
Date reported
4 January 2023
Last updated
6 January 2026
Public ID
PID-GR8DY9
If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .
If you export goods you can check duties and customs procedures for your chosen market.